Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	11.7	32.3	21.5	8.3	33.1	7.4	12.1	18.7	32.4	26.9	22.1	19.6	19.6	32.0	25.1	53.3	13.8	26.9	22.3	19.4	22.8	21.1	26.4	20.3	24.3	10.7	20.3	23.6	33.1	18.5	1.3	16.6	18.5	22.4	18.5	24.8	17.5	17.4	19.5	25.5	9.1	46.9	17.9	18.6	11.7	27.8	27.7	17.4	12.1	33.4	9.0	14.6	19.3	12.7	6.7	13.8	13.2	9.6	8.9	10.1	5.7	0.0	0.1	13.5	0.0	35.3	23.8	12.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	11.6	33.7	9.5	3.3	29.1	9.6	0.0	0.0	22.5	0.0	0.0	29.0	0.0	0.0	27.3	13.3	12.4	0.0	12.6	29.0	8.2	23.0	17.3	17.7	29.2	7.3	0.0	6.3	0.0	0.0	4.2	0.1	0.0	0.1	8.8	0.0	0.0	0.0	13.4	4.3	15.1	14.6	16.9	0.0	5.8	0.0	5.0	0.0	0.0	10.6	10.1	4.4	17.4	0.0	0.0	2.7	5.7	13.2	9.2	9.6	8.7	6.7	5.8	10.1	10.3	5.9	5.0	7.3	11.0	8.9	6.6	13.8	7.8	5.7	21.5	33.1	18.7	32.4	22.8	21.1	20.3	23.6	22.4	17.4	14.9	18.1	19.4	9.5	8.0	26.4	3.1	12.7	12.0	7.9	34.9	11.8	28.8	5.0	16.4	52.8	13.5	30.7	0.0	12.4	25.8	14.4	11.5	12.7	27.1	22.0	30.2	28.3	18.4	17.4	64.8	12.4	17.4	8.5	5.4	24.1	34.1	13.6	21.0	20.1	22.3	17.0	0.0	20.8	45.5	20.6	3.1	12.8	12.1	20.4	10.5
AGPAT2	"BSCL, LPAAT-beta"	ENSG00000169692	"1-acylglycerol-3-phosphate O-acyltransferase 2"	O15120	9	136673143-136687423	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 71.5;liver: 63.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 930.5;Paneth cells: 350.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 50.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019544	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA019544: AB_1844646"	"unprognostic (3.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.01e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.30e-3)"	"unprognostic (5.06e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.61e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.93e-1)"	71.5	5.3	2.3	8.1	2.2	8.4	35.2	2.0	3.0	7.4	20.2	2.2	5.9	31.3	4.7	7.1	11.7	4.1	15.8	12.4	2.8	2.4	10.9	63.1	12.1	11.1	2.5	2.8	5.3	47.7	2.5	6.2	4.9	2.6	5.5	3.3	8.9	12.9	6.2	9.5	7.0	33.6	4.0	1.9	6.8	11.0	5.2	1.9	5.1	13.4	7.0	8.8	6.6	4.9	7.0	20.3	33.2	28.4	2.1	2.5	9.8	14.7	20.8	2.4	11.5	17.9	5.6	10.5	9.8	7.8	6.7	5.1	23.6	29.2	4.9	22.1	5.6	10.9	40.1	3.5	6.1	0.7	50.5	15.9	7.2	8.6	5.1	12.3	7.5	17.6	5.3	8.5	5.7	3.0	5.8	3.5	6.6	8.7	0.8	2.8	26.6	0.5	23.5	6.3	27.2	37.8	11.1	8.9	26.9	7.9	9.3	5.5	8.9	12.7	13.4	16.1	2.0	8.5	29.8	6.8	8.9	9.2	2.9	6.2	1.2	0.1	3.1	0.1	16.3	8.9	6.0	28.4	33.2	2.2	25.3	2.1	4.1	1.9	2.5	14.9	7.0	1.6	1.8	19.1	2.1	22.2	20.3	2.3	9.8	2.3	2.2	2.0	3.0	2.8	2.4	2.5	2.8	2.6	1.9	14.9	59.7	17.6	50.1	40.2	2.1	34.7	68.8	10.7	18.2	69.8	0.0	6.7	46.4	135.1	138.9	26.4	930.5	0.0	193.7	28.9	36.3	80.5	13.8	203.0	114.8	38.1	34.3	22.1	50.6	271.0	24.7	62.8	129.9	36.9	126.5	13.3	140.9	350.7	19.1	33.5	3.6	45.3	29.6	1.1	36.6	71.0	5.7	20.3	115.8	138.0
AGPAT3	LPAAT-gamma	ENSG00000160216	"1-acylglycerol-3-phosphate O-acyltransferase 3"	Q9NRZ7	21	43865186-43986536	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.1"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 172.8;Early spermatids: 230.1;Late spermatids: 164.7;Rod photoreceptor cells: 181.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.36e-2)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.50e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (1.50e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.60e-2)"	12.0	10.2	21.5	11.1	23.0	5.8	12.7	14.6	22.7	6.4	20.1	18.9	8.5	27.4	5.1	10.4	13.4	8.1	8.6	11.6	19.9	15.1	33.8	30.2	9.9	9.0	21.7	11.4	5.4	12.7	17.1	7.3	7.6	13.6	7.9	7.6	10.6	24.0	8.0	59.1	10.2	34.6	5.8	25.2	10.2	11.1	11.7	11.4	7.2	14.1	15.0	7.0	9.8	6.6	1.3	4.5	2.4	10.6	0.7	3.5	2.0	26.9	15.4	3.8	10.5	7.8	8.6	3.0	12.5	15.7	15.9	9.8	15.1	19.7	9.1	9.5	14.8	14.9	10.5	6.6	13.8	4.6	43.5	17.6	4.0	9.5	20.2	13.6	14.7	9.1	10.2	11.9	14.0	5.9	14.9	11.9	3.1	22.5	15.1	5.7	11.6	0.1	9.1	1.8	10.7	10.9	15.1	4.4	24.6	12.6	26.6	13.3	9.7	15.2	17.4	11.6	1.6	12.0	16.0	17.6	10.1	0.1	15.1	12.7	12.1	18.0	5.7	13.1	29.4	9.1	0.0	4.1	2.4	1.5	8.9	1.5	1.3	2.1	2.2	4.5	1.2	1.7	1.9	1.0	0.7	10.6	1.1	3.5	2.0	21.5	23.0	14.6	22.7	19.9	15.1	21.7	11.4	13.6	11.4	11.9	23.1	7.5	7.5	7.1	36.1	31.3	20.4	32.1	22.7	24.4	172.8	13.2	8.3	23.9	230.1	11.7	47.3	0.0	25.5	0.7	8.9	14.4	4.7	59.5	16.9	62.0	13.3	15.4	24.3	164.7	7.2	22.0	1.7	27.9	21.9	27.1	23.5	20.1	5.3	42.8	181.7	6.5	7.8	9.0	2.1	9.7	10.1	9.2	19.3	12.2
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129979-161274061	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.0"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 51.8;Late spermatids: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 19.8;HEL: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	5.6	4.2	10.5	3.5	19.1	8.0	4.5	9.6	26.6	5.3	4.2	35.6	1.0	2.6	10.7	4.5	5.2	7.2	8.0	2.9	14.2	11.8	5.2	2.0	6.1	2.0	25.8	12.4	10.0	2.3	1.3	9.8	14.6	27.4	3.7	4.4	0.7	2.7	4.9	2.1	1.9	2.5	8.5	49.0	5.2	3.0	4.2	19.8	0.6	4.8	2.0	2.2	4.0	3.8	1.1	1.9	0.6	3.5	5.8	7.0	2.1	0.3	0.8	19.8	3.9	3.7	7.6	0.8	0.7	0.2	1.5	2.5	1.1	3.5	0.5	1.4	3.1	9.2	0.3	3.6	3.0	1.4	2.2	6.2	14.8	3.5	0.0	2.9	0.1	2.1	9.1	1.5	4.0	2.1	7.1	4.6	2.3	7.3	6.8	1.8	0.0	1.0	1.6	4.7	0.0	7.5	0.0	0.9	0.4	4.3	0.3	11.5	4.4	3.0	1.6	0.8	8.1	0.8	1.0	5.1	2.1	2.6	1.4	3.3	0.5	0.7	0.0	7.8	0.8	1.3	0.0	3.5	0.0	7.0	2.8	2.3	0.4	3.3	4.1	1.9	1.1	1.7	2.7	0.6	5.8	2.5	1.5	2.9	2.1	10.5	19.1	9.6	15.8	14.2	11.8	25.8	12.4	27.4	19.8	3.0	5.6	5.2	4.6	2.9	1.0	4.0	2.5	10.7	5.7	5.2	0.0	16.0	0.0	4.3	51.8	12.2	0.0	0.0	7.0	10.7	11.3	0.8	10.5	0.4	16.7	0.0	1.7	9.8	7.6	44.8	5.5	15.4	3.3	11.8	0.0	4.0	5.9	0.0	8.1	0.3	0.9	19.4	6.2	3.6	2.9	2.3	18.5	7.4	0.0	3.2
AGPAT5	"FLJ11210, LPAAT-e, LPAAT-epsilon"	ENSG00000155189	"1-acylglycerol-3-phosphate O-acyltransferase 5"	Q9NUQ2	8	6708357-6759666	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010644, HPA010950, HPA011646"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA010644: AB_1844647, HPA010950: AB_1844648, HPA011646: "	"unprognostic (1.05e-3)"	"unprognostic (4.69e-1)"	"prognostic favorable (8.82e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.44e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.09e-3)"	5.9	12.5	20.0	8.5	20.7	5.1	9.8	10.0	21.2	6.0	12.2	16.5	6.8	9.3	9.3	19.1	8.4	9.7	5.9	4.0	19.3	16.9	14.2	14.3	5.1	16.8	18.7	9.5	6.4	16.2	11.4	18.5	16.3	14.2	11.0	12.3	3.3	5.4	16.0	10.2	5.1	8.4	8.6	30.6	8.6	11.0	30.8	12.7	14.3	7.3	6.8	10.4	7.3	5.7	11.0	8.4	3.0	4.8	5.3	3.9	2.9	9.4	7.6	11.9	7.0	3.1	5.1	10.6	5.0	5.2	7.5	7.3	4.7	7.5	20.7	3.3	3.3	10.5	11.2	9.1	10.1	13.2	4.5	6.2	25.4	5.9	10.6	7.9	10.6	11.1	6.8	8.6	7.3	9.8	6.9	13.1	8.7	18.7	11.1	12.3	6.1	19.2	13.1	20.8	12.7	5.9	13.9	14.3	8.1	6.8	13.3	24.4	12.8	4.8	8.8	9.5	7.3	4.0	14.0	5.4	12.3	5.8	4.7	13.9	4.2	12.8	11.3	7.2	12.8	14.6	3.0	4.1	2.6	1.9	4.8	3.9	8.7	3.0	3.3	2.7	11.0	2.3	2.7	0.4	5.3	4.2	8.4	2.7	2.9	20.0	20.7	10.0	14.6	19.3	16.9	18.7	9.5	14.2	12.7	3.0	4.1	16.6	10.5	8.0	7.7	5.3	12.7	10.7	7.9	7.0	2.0	7.7	3.3	8.4	29.8	15.8	11.4	0.0	8.5	10.7	5.7	13.4	17.4	29.2	11.0	6.4	21.2	8.6	14.0	22.9	14.7	6.4	6.8	1.0	7.9	37.9	8.0	8.6	14.5	17.4	8.8	6.5	13.2	20.9	8.6	9.2	15.4	4.4	20.0	10.6
CEL	"BSSL, MODY8"	ENSG00000170835	"Carboxyl ester lipase"		9	133061978-133071861	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	348	"pancreas: 1584.8"	"Cell type enriched"	"Detected in some"	19	"Exocrine glandular cells: 809.5"	"Cancer enriched"	"Detected in many"	29	"pancreatic cancer: 469.3"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"JURKAT: 9.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA008023, HPA052701"	Enhanced				"Secreted to digestive system"	NA	NA					"HPA008023: AB_1846509, HPA052701: AB_2681921"	"prognostic unfavorable (4.14e-4)"	"unprognostic (2.30e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.98e-1)"	"unprognostic (4.41e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.02e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0.0	4.5	0.2	0.2	0.2	0.0	0.2	0.2	4.5	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	4.2	2.6	1.4	1.0	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2.0	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1.0	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2.0	2.6	2.3	0.5	0.5	4.2	1.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.2	2.3	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.7	0.0	0.7	1.6	2.5	0.0	0.0	0.0	0.0	0.1	3.3	1.7	0.2	0.0	3.3	0.0	809.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	11.8	0.0	1.1	42.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.3	0.3	0.0	1.2	1.7
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 291.1;Paneth cells: 112.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.2	2.0	3.6	3.2	1.3	2.3	2.8	2.7	2.6	1.8	9.7	2.6	1.5	10.7	1.7	1.3	3.3	1.6	3.8	0.6	2.8	4.0	2.8	3.4	15.8	2.3	0.7	2.9	1.8	2.9	1.7	1.9	1.8	2.0	4.9	2.2	3.6	1.7	3.2	4.8	3.1	0.9	9.2	17.6	6.3	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	0.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.1	0.4	0.6	1.5	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2	14.9	21.3	6.5	9.8	7.1	24.2	17.9	15.3	4.0	7.9	17.4	27.5	10.2	1.7	6.8	13.4	13.5	291.1	0.0	10.4	8.3	7.1	8.8	6.9	49.5	16.5	17.5	22.4	10.4	25.4	16.4	6.4	15.0	5.0	1.0	70.1	18.1	11.4	112.2	6.3	6.8	21.9	0.0	10.5	25.1	15.9	8.2	13.7	8.5	84.8	18.4
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.3;blood: 68.9;liver: 81.3"	"Cell type enhanced"	"Detected in many"	19	"Early spermatids: 192.0;Hepatocytes: 104.6;Late spermatids: 49.3;Spermatocytes: 45.4;Spermatogonia: 49.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"eosinophil: 26.3;neutrophil: 68.9"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 68.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 30.3;HDLM-2: 22.0;Hep G2: 22.9;OE19: 44.2"	"Low region specificity"	"Detected in all"							HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	104.3	1.3	1.9	12.5	6.8	1.7	30.4	0.1	4.2	1.0	11.8	0.6	0.4	3.6	0.5	0.6	6.3	0.7	6.3	6.0	1.0	1.2	1.0	81.3	1.8	16.1	0.6	1.2	0.6	1.3	0.4	0.6	0.5	1.0	1.0	1.4	1.2	9.9	0.6	1.3	34.1	8.1	0.9	0.6	3.7	3.3	13.6	0.5	1.0	2.4	3.9	4.5	4.0	2.7	1.5	1.1	68.9	4.2	0.0	0.0	0.9	4.6	2.3	0.1	4.0	30.3	2.4	0.3	0.4	0.5	0.6	0.3	16.7	4.9	7.4	6.2	0.1	4.4	0.1	0.6	2.3	1.6	22.0	0.4	0.5	1.6	22.9	0.3	2.6	2.6	10.1	12.4	2.7	3.9	1.6	0.4	7.5	0.4	10.1	0.2	3.0	1.7	5.7	1.3	44.2	10.9	0.0	0.0	8.7	0.4	12.9	8.3	0.5	4.2	0.7	1.0	1.0	1.6	9.3	0.5	5.3	2.6	0.1	3.2	5.9	13.2	9.9	3.8	8.4	9.0	3.0	4.2	26.3	0.0	0.8	0.0	1.5	0.0	0.0	1.1	1.2	0.0	0.0	68.9	0.0	0.8	0.3	0.0	0.9	1.9	6.8	0.1	4.2	1.0	1.2	0.6	1.2	1.0	0.5	6.0	4.8	3.4	0.8	1.0	0.6	3.4	0.0	1.4	1.2	0.0	2.0	0.5	0.0	1.4	192.0	0.3	0.4	0.0	0.4	0.1	0.8	2.0	0.0	104.6	2.3	1.6	1.2	1.3	5.6	49.3	2.0	1.7	1.7	0.0	5.0	0.5	2.1	2.6	0.7	1.7	0.0	6.5	0.3	45.4	49.4	6.9	0.7	0.0	3.4	4.2
GNPAT	"DAP-AT, DAPAT, DHAPAT"	ENSG00000116906	"Glyceronephosphate O-acyltransferase"	O15228	1	231241207-231277973	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.87e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.29e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.68e-1)"	14.7	20.1	18.3	17.9	17.0	9.6	34.6	18.9	17.8	12.6	18.6	14.7	16.6	18.9	13.9	16.0	14.5	18.4	13.5	39.3	16.9	13.9	16.7	19.5	20.3	24.4	17.1	15.0	15.3	26.7	14.3	15.0	12.3	16.5	15.3	16.3	10.8	20.6	18.0	61.1	14.9	19.1	24.7	17.7	13.5	18.0	26.5	15.0	16.2	13.6	20.2	15.9	14.4	13.6	23.7	23.8	23.4	30.3	16.4	23.9	18.5	14.8	16.6	23.6	17.8	19.4	28.8	15.9	12.6	14.3	13.4	15.4	21.2	18.6	21.4	15.9	18.8	14.1	16.1	15.6	17.1	19.8	24.2	14.3	15.4	16.3	30.5	19.8	26.2	12.3	20.0	21.0	13.8	15.6	17.5	31.3	21.5	22.5	20.6	27.7	4.8	23.3	15.2	37.8	42.2	19.1	25.7	31.6	25.0	16.7	11.1	15.7	22.4	21.1	11.9	18.3	9.8	20.8	41.7	16.3	13.6	12.8	19.6	31.2	26.7	33.9	24.7	19.6	22.2	25.2	17.7	24.1	23.4	16.5	24.0	19.0	23.2	21.6	21.6	23.8	23.7	19.1	17.4	9.5	16.4	30.3	11.3	23.9	18.5	18.3	17.0	18.9	17.8	16.9	13.9	17.1	15.0	16.5	15.0	23.8	14.4	37.4	17.0	11.9	22.4	48.8	28.1	29.4	17.0	26.2	37.3	21.3	14.9	34.5	55.1	21.5	15.8	0.0	37.7	16.2	18.4	21.6	11.5	23.2	24.4	11.1	27.1	16.0	21.2	86.2	23.6	22.5	11.8	25.2	19.8	22.6	34.7	35.1	25.1	22.8	23.3	19.4	22.5	39.6	31.0	12.2	10.4	23.2	31.5	16.0
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149864-112215377	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 107.3;liver: 56.6"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 165.5;Horizontal cells: 42.9"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 76.6;Hep G2: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"	107.3	17.2	11.4	2.6	12.1	1.8	30.8	6.6	11.0	2.0	3.2	6.5	5.1	2.2	4.1	32.1	2.4	1.9	3.0	5.8	12.2	2.9	2.4	56.6	2.2	2.3	7.2	7.3	3.5	2.8	3.2	2.3	1.8	5.6	2.3	2.6	12.0	6.8	2.9	3.6	1.8	3.3	3.4	3.8	1.7	2.4	2.8	7.2	2.8	6.1	2.4	2.3	3.2	1.6	3.2	2.0	0.5	1.2	1.1	3.4	1.0	2.8	2.1	2.9	3.8	76.6	2.8	3.8	2.7	3.1	1.9	1.5	5.0	1.7	2.0	1.5	1.9	1.8	3.6	4.6	2.3	3.7	1.4	2.4	1.8	2.3	20.6	2.3	3.2	1.0	13.4	3.9	3.5	7.1	15.0	1.7	2.8	2.3	1.8	2.2	1.6	2.7	2.5	2.4	1.6	3.0	2.7	7.6	1.4	1.3	1.9	1.2	3.6	3.7	1.8	4.2	2.8	1.8	1.1	1.3	2.3	1.4	2.8	4.2	1.8	2.0	4.2	2.6	2.8	1.7	0.0	1.0	0.5	2.5	1.2	3.2	1.9	1.9	1.9	1.2	3.2	2.0	3.4	0.0	1.1	1.0	2.0	1.9	1.0	11.4	12.1	6.6	11.0	12.2	2.9	7.2	7.3	5.6	7.2	8.9	19.0	7.8	0.6	0.3	5.8	15.7	17.8	5.3	5.7	5.2	9.8	4.6	1.7	2.5	0.4	4.5	1.7	0.0	2.8	2.1	2.5	1.2	2.3	165.5	2.5	42.9	1.2	5.5	8.9	0.4	4.9	2.1	1.7	0.0	3.8	6.0	2.6	2.9	11.3	2.7	8.9	6.5	1.9	2.9	3.2	0.1	1.6	3.2	4.5	0.5
GPAT2	CT123	ENSG00000186281	"Glycerol-3-phosphate acyltransferase 2, mitochondrial"	Q6NUI2	2	96021946-96039451	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 97.0;Smooth muscle cells: 18.3;Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 7.1;BJ hTERT+ SV40 Large T+: 17.5;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HBF TERT88: 4.0;OE19: 11.9;U-2 OS: 10.0"	"Low region specificity"	"Detected in single"							HPA036841	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036841: AB_10601479"	"unprognostic (1.42e-2)"	"unprognostic (2.39e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.43e-6)"	"unprognostic (2.11e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.65e-1)"	4.3	1.1	1.5	1.9	3.1	1.5	3.6	0.2	1.6	0.8	1.0			0.0	1.1	5.1	0.9	1.0	2.2	3.9	1.1	0.7	0.5	0.5	1.3	3.2	1.2		0.9	1.1	0.0	0.2	2.0		0.6	1.5		1.8	4.9	1.4	0.5	1.3	2.4	2.3	4.4	3.0	7.3			1.2		2.6	2.6	0.8	4.3	1.1	0.5	2.5	0.2	3.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.1	0.0	17.5	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	2.6	1.9	2.8	4.3	1.3	2.0	1.1	4.1	0.8	3.0	0.0	0.2	2.5	0.0	1.3	1.5											0.0	0.6	2.4	0.6	0.9	0.7	1.6	2.5	0.0	0.0	1.8	0.0	0.1	1.7	1.7	1.5	2.9	0.4	0.0	1.6	0.2	2.2	0.5	1.1	0.0	2.2	7.9	0.0	6.7	1.0	4.3	0.6	1.0	1.7	1.0	0.7	0.9	0.8	0.6	0.0	0.0	0.2	97.0	18.3	27.9	16.8	0.1	0.1	0.7	1.3	1.6
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	9.8	9.7	0.0	0.1	0.5	1.2	0.2	0.7	1.4	0.2	0.2	0.7	51.6	0.0	1.1	1.8	39.2	2.2	4.6	0.9	0.1	0.6	2.2	0.0	3.1	9.5	1.4	2.8	19.0	0.6	0.0	0.3	1.1	3.8	4.8	2.7	7.9	7.8	0.2	1.0	0.7	0.7	0.2	14.5	4.2	0.1	2.2	3.7	9.8	0.6	0.2	0.0	1.9	2.0	5.4	0.5	0.4	0.5	0.2	2.3	4.2	2.3	9.3	0.4	0.6	0.0	22.6	5.6	17.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4	6.0	5.0	0.0	41.3	0.0	0.0	0.0	7.6	2.7	9.1	10.4	0.0	0.2	13.3	1.6	68.5	0.6	21.6	0.0	5.9	1.0	0.1	25.8	7.0	11.9	15.3	4.8	1.2	5.5	16.7	17.2	1.1	28.3	0.0	5.4	4.8	0.0	6.6	8.0	0.7	50.3	0.2	6.5	0.0	8.8	1.7	0.0	0.8	0.0	2.1	25.4
GPAT4	"AGPAT6, DKFZp586M1819, LPAAT-zeta, TSARG7"	ENSG00000158669	"Glycerol-3-phosphate acyltransferase 4"	Q86UL3	8	41577187-41625001	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016471	Approved					NA	NA					"HPA016471: AB_1844649"	"unprognostic (3.05e-2)"	"unprognostic (4.05e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.08e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (1.98e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (1.73e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (5.65e-4)"	15.7	27.4	14.4	17.8	17.2	16.6	28.1	43.8	21.9	16.9	14.0	23.1	22.7	13.0	22.8	12.0	13.1	14.6	15.8	14.1	14.0	13.1	20.8	26.7	18.7	13.8	18.5	13.6	16.6	17.3	35.7	22.3	23.3	20.5	15.1	15.1	21.0	20.8	15.5	42.1	14.5	14.6	23.0	18.0	17.5	17.8	15.5	16.6	15.2	14.5	12.4	19.4	16.6	14.9	9.1	18.9	10.8	15.0	4.9	12.1	11.1	14.7	16.4	19.7	15.4	21.6	26.3	17.3	32.2	27.7	24.4	25.6	11.0	29.8	20.6	22.6	26.5	30.1	8.6	23.0	14.5	31.7	22.0	12.7	24.0	18.3	10.1	12.6	2.5	34.7	16.5	10.7	25.4	9.2	21.0	25.1	20.6	17.9	24.3	25.0	6.3	22.4	6.5	21.0	27.3	8.8	13.2	19.7	11.1	14.8	22.2	12.9	17.8	12.5	17.3	34.5	23.6	24.0	16.3	18.2	25.3	17.8	28.9	24.0	13.1	17.6	22.5	20.8	14.2	24.7	10.8	15.0	6.6	12.1	14.3	11.3	8.3	9.3	11.9	18.9	9.1	8.5	8.2	3.5	4.9	12.0	7.1	8.7	11.1	14.4	17.2	43.8	21.9	14.0	13.1	18.5	13.6	20.5	16.6	3.0	37.7	8.0	11.2	0.0	15.6	0.0	30.6	10.7	25.0	10.4	9.8	29.1	3.3	35.3	36.6	18.0	10.2	70.0	34.4	34.1	9.3	25.6	2.3	53.8	22.9	14.3	16.4	20.9	29.5	44.4	11.8	16.4	0.0	37.9	19.7	12.7	36.5	14.0	9.9	23.5	12.1	6.5	0.0	3.0	13.4	0.0	33.8	10.2	13.3	13.6
LIPC	"HL, HTGL"	ENSG00000166035	"Lipase C, hepatic type"	P11150	15	58410569-58569843	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 91.7"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 125.3"	"Group enriched"	"Detected in some"	14	"liver cancer: 20.4;renal cancer: 10.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		3200000				"unprognostic (1.76e-2)"	"unprognostic (9.15e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.15e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.27e-2)"	0.2	0.1	0.4	1.1	0.7	0.0	0.7	0.1	0.4	0.3	0.2	0.6	0.0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3.0	91.7	0.3	0.2	1.2	0.2	0.3	1.0	0.0	1.0	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0.0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3.0	4.5	2.5	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.7	0.0	0.0	7.0	0.0	0.0	5.3	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.5	0.0	20.0	0.4	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	4.5	0.6	0.0	0.0	0.0	0.9	0.3	0.0	2.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	15.8	0.0	0.0	0.0	0.1	0.1	0.4	0.0	3.7	0.3	0.0	3.0	0.2	4.5	0.0	0.8	2.2	0.2	0.1	1.0	3.2	0.4	3.0	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0.0	0.0	5.1	0.0	0.2	0.0	0.8	12.7	0.0	1.2	3.5	0.0	0.0	5.0	3.7	0.0	0.0	0.0	0.0	3.3	0.0	1.2	0.2	0.0	125.3	0.1	0.0	0.0	5.5	4.0	0.0	0.3	0.0	1.7	1.0	0.0	0.0	0.3	0.0	0.0	9.6	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 762.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	75	"stomach cancer: 278.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Cell type enriched"	"Detected in single"	16	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 6.4;MOLT-4: 5.0;NTERA-2: 5.3;REH: 3.1;THP-1: 10.0;U-2 OS: 3.6;U-266/70: 4.9"	"Region enriched"	"Detected in single"	51	"olfactory region: 9.9"					HPA045930	Enhanced				"Secreted to digestive system"	NA	NA					"HPA045930: AB_10959518"										"unprognostic (1.53e-1)"				"unprognostic (1.83e-1)"				0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.1	1.9	0.1	0.2	28.2	0.1	8.2	0.1	0.1	31.6	0.1	0.6	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	9.9	0.1	0.1	0.0	0.1	0.1	0.1	0.1	762.9	0.1	0.1	0.2	0.1	1.1	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	5.3	0.0	0.0	3.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	1.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in many"			HPA016966	Uncertain				"Secreted to blood"	NA	NA	657000000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.8	31.4	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.6	4.9	0.0	7.6	0.0	9.6	48.1	2.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	11.1	4.9	9.6	0.1	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.1	0.0	0.0	0.7	32.0	3.7	0.2	0.0	0.2	0.3	0.0	1.8	0.0	0.0	62.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4	0.0	1.4	0.0	4.8	1.5	0.8	1.7	25.5	0.0	3.4	14.0	56.9	4.7	0.0	3.2	8.0	1.4	9.5	0.0	1.2	60.0	1.0	8.4	0.0	66.8	1.6	0.0	13.3	4.9	1.9	6.0	0.3	0.0	1.7	1.0	3.4	1.0	7.7	2.9	0.0	1.0	2.4	0.0	0.7	1.0	0.8	2.3	16.2	0.7	6.2	9.9
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
MBOAT2	"FLJ14415, FLJ90298, OACT2"	ENSG00000143797	"Membrane bound O-acyltransferase domain containing 2"	Q6ZWT7	2	8852690-9003813	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 34.7"	"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 133.5;Muller glia cells: 95.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014836	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014836: AB_1854745"	"unprognostic (2.49e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.13e-9)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.97e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.66e-2)"	"prognostic unfavorable (5.32e-4)"	2.3	2.9	12.8	2.9	18.0	24.2	10.1	10.1	20.2	6.0	8.2	16.6	1.2	3.1	5.3	3.5	14.2	3.7	4.3	5.1	14.7	12.4	8.0	1.3	10.9	2.9	23.3	10.3	6.8	2.1	34.7	5.5	3.8	16.2	16.1	9.3	6.4	5.6	4.1	1.2	12.3	4.3	4.6	18.5	2.5	6.9	2.7	17.8	1.9	5.3	16.1	10.3	4.4	7.5	0.0	0.8	6.7	0.7	0.0	0.2	0.3	8.4	2.6	7.9	3.4	3.6	8.0	4.6	4.1	1.5	5.3	3.5	0.7	13.5	2.4	4.9	9.7	4.2	6.5	7.0	8.2	8.0	7.5	12.1	10.1	3.7	0.0	4.4	0.0	3.2	5.8	4.9	5.0	3.5	11.7	2.8	3.5	8.6	1.9	4.6	2.2	3.0	0.2	3.1	3.8	10.0	4.5	12.5	0.1	7.8	1.2	4.7	14.5	4.2	25.5	4.0	4.1	4.8	2.9	1.5	9.4	5.0	7.2	11.6	0.7	0.2	2.7	14.7	1.4	3.1	6.3	0.7	2.8	0.0	0.2	0.0	0.0	0.2	0.1	0.8	0.0	0.2	0.1	6.7	0.0	0.2	0.1	0.0	0.3	12.8	18.0	10.1	15.8	14.7	12.4	23.3	10.3	16.2	17.8	17.9	10.1	4.5	2.9	3.0	18.3	10.6	5.1	16.0	19.4	38.4	7.9	2.5	5.0	4.5	7.3	8.8	10.3	46.7	1.4	1.3	9.8	21.0	8.1	0.0	1.7	133.5	36.0	4.3	2.1	7.8	4.9	4.3	13.5	44.1	49.8	95.3	52.2	20.4	7.1	8.4	7.2	6.5	12.0	10.7	23.7	4.4	1.6	2.1	11.9	29.8
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
MOGAT1	"DGAT2L, DGAT2L1, MGAT1"	ENSG00000124003	"Monoacylglycerol O-acyltransferase 1"	Q96PD6	2	222671786-222709930	"Enzymes, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"gallbladder: 40.9"	"Cell type enhanced"	"Detected in some"	13	"Cholangiocytes: 5.1;Exocrine glandular cells: 4.5;Hepatocytes: 2.1;Muller glia cells: 2.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 3.4"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 3.4"	"Cell line enhanced"	"Detected in single"		"Hep G2: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049944	Uncertain					NA	NA					"HPA049944: AB_2680964"	"unprognostic (6.32e-2)"		"unprognostic (2.38e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.41e-1)"		"unprognostic (4.28e-3)"	"unprognostic (4.39e-2)"	"unprognostic (4.32e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-1)"	"unprognostic (9.03e-3)"		2.3	0.1	0.6	0.1	0.5	0.1	1.3	0.2	0.9	0.3	0.6	0.5	0.2	0.0	1.0	1.1	0.5	0.1	40.9	0.8	0.5	0.2	5.7	7.6	1.1	0.3	0.2	0.9	0.1	1.5	2.3	0.4	0.0	0.9	0.2	0.1	0.0	1.4	2.6	0.5	1.6	0.2	0.1	0.3	0.1	1.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.5	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.6	0.5	0.2	0.9	0.5	0.2	0.2	0.9	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717819-75732958	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 90.2;liver: 40.5"	"Cell type enhanced"	"Detected in some"	19	"Enterocytes: 91.9;Hepatocytes: 64.7;Mucus-secreting cells: 33.4;Undifferentiated cells: 25.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 8.6;RPMI-8226: 5.8"	"Not detected"	"Not detected"							HPA028834	Uncertain					NA	NA					"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.1	0.0	0.1	4.8	0.1	0.0	2.1	0.1	0.1	0.2	34.0	0.1	1.4	22.3	0.1	0.1	0.2	0.0	2.6	0.1	0.1	0.0	0.2	40.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	7.0	0.1	0.4	2.2	0.4	0.9	90.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.1	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.9	0.0	0.5	0.0	0.0	0.8	0.0	64.7	0.0	0.0	2.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	18.7	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	0.1
PLA2G3	GIII-SPLA2	ENSG00000100078	"Phospholipase A2 group III"	Q9NZ20	22	31134809-31140607	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 13.1;skin 1: 14.1;tongue: 17.4"	"Cell type enriched"	"Detected in some"	7	"Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021016	Uncertain				"Secreted to blood"	NA	NA					"HPA021016: AB_1855443"	"unprognostic (1.80e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (4.47e-4)"		"unprognostic (1.74e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.55e-3)"	"unprognostic (4.41e-1)"		"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.49e-3)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.2	0.0	2.0	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0.0	0.1	0.1	0.6	0.0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0.0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	14.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.9	0.6	0.0	0.1	0.4	3.1	0.1	0.0	2.2	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	15.6	0.0	0.0	0.0	0.4
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 3478.1"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	NA	NA		13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.1	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.5	0.0	0.0	0.0	3478.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	826.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PNLIPRP1	PLRP1	ENSG00000187021	"Pancreatic lipase related protein 1"	P54315	10	116590385-116609175	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2629	"pancreas: 516.5"	"Cell type enriched"	"Detected in some"	5	"Exocrine glandular cells: 576.9"	"Cancer enriched"	"Detected in single"	475	"pancreatic cancer: 32.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"EFO-21: 1.1;U-2 OS: 1.8;U-266/84: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to digestive system"	NA	NA		210000						"unprognostic (1.21e-1)"	"unprognostic (4.08e-3)"						"unprognostic (1.40e-1)"	"unprognostic (1.80e-1)"		"unprognostic (2.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	0.0	576.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.6	0.1	0.0	108.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 37.1;Cholangiocytes: 15.3;Cone photoreceptor cells: 17.7;Hepatocytes: 42.7;Rod photoreceptor cells: 34.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.5;LHCN-M2: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			Nucleoli	"Mitochondria, Cytosol"	"HPA058058: AB_2683590"	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.3	13.5	5.5	3.8	4.3	0.4	2.4	1.4	3.3	7.2	3.9	7.1	0.0	2.1	4.0	1.9	3.4	8.4	3.9	2.8	0.0	0.7	0.2	3.2	7.2	6.2	0.0	0.2	4.9	3.1	10.6	0.5	5.7	0.4	0.1	0.0	0.0	15.3	0.6	0.2	0.0	9.2	0.4	0.0	0.0	7.3	0.1	1.5	0.2	1.2	0.1	2.7	1.1	3.8	2.4	4.2	4.6	0.4	1.3	4.1	0.1	0.1	0.0	0.0	0.0	11.6	0.0	4.8	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3	0.0	0.0	0.0	0.5	0.3	37.1	1.1	15.3	0.0	0.0	0.0	17.7	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.4	0.0	42.7	0.6	0.0	1.7	0.6	2.6	0.0	0.3	0.0	1.7	0.0	0.5	1.3	1.5	0.0	0.7	5.0	34.3	0.0	0.0	0.4	0.7	0.1	0.0	0.0	0.0	0.4
